$279 Million is the total value of Krensavage Asset Management, LLC's 22 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BXLT | Sell | BAXALTA INC | $29,689,000 | +3.0% | 734,885 | -0.5% | 10.65% | +15.9% |
| OFIX | Buy | ORTHOFIX INTERNATIONAL NV | $26,703,000 | +6.4% | 643,145 | +0.5% | 9.58% | +19.6% |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $25,920,000 | -10.6% | 882,529 | +0.5% | 9.30% | +0.5% |
| UTHR | Buy | UNITED THERAPEUTICS CORP | $24,898,000 | -25.9% | 223,445 | +4.2% | 8.93% | -16.6% |
| TEVA | Buy | TEVA PHARMACEUTICAL-SP ADR | $21,111,000 | -18.1% | 394,519 | +0.5% | 7.58% | -7.9% |
| IPXL | Buy | IMPAX LABORATORIES INC | $18,824,000 | -24.8% | 587,882 | +0.5% | 6.75% | -15.4% |
| HYH | Sell | HALYARD HEALTH INC | $16,155,000 | -14.4% | 562,289 | -0.5% | 5.80% | -3.8% |
| Sell | AMGEN INC | $16,081,000 | -8.1% | 107,255 | -0.5% | 5.77% | +3.4% | |
| RTIX | Buy | RTI SURGICAL INC | $13,788,000 | +12.9% | 3,447,090 | +12.0% | 4.95% | +26.9% |
| CNMD | Sell | CONMED CORP | $13,734,000 | -5.2% | 327,460 | -0.5% | 4.93% | +6.6% |
| MRK | Buy | MERCK & CO. INC. | $13,557,000 | +0.6% | 256,222 | +0.5% | 4.86% | +13.2% |
| Buy | INDIVIOR PLC | $11,020,000 | -14.9% | 4,703,007 | +0.5% | 3.95% | -4.4% | |
| IVC | Buy | INVACARE CORP | $8,053,000 | +9.4% | 611,485 | +44.5% | 2.89% | +23.0% |
| AGN | Sell | ALLERGAN PLC | $7,041,000 | -14.6% | 26,270 | -0.5% | 2.53% | -4.0% |
| SPPI | Sell | SPECTRUM PHARMACEUTICALS INC | $6,946,000 | +5.0% | 1,092,162 | -0.5% | 2.49% | +18.0% |
| DEPO | Sell | DEPOMED INC | $6,227,000 | -23.5% | 447,000 | -0.4% | 2.23% | -13.9% |
| SCMP | Buy | SUCAMPO PHARMACEUTICALS-CL A | $6,101,000 | -36.5% | 558,229 | +0.5% | 2.19% | -28.6% |
| Buy | BIOTA PHARMACEUTICALS INC | $4,042,000 | -20.6% | 2,694,601 | +2.6% | 1.45% | -10.8% | |
| DSCI | Buy | DERMA SCIENCES INC | $2,809,000 | -31.8% | 906,046 | +0.5% | 1.01% | -23.3% |
| DRAD | Sell | DIGIRAD CORP | $2,375,000 | -14.7% | 478,756 | -0.5% | 0.85% | -4.2% |
| JNP | Sell | JUNIPER PHARMACEUTICALS INC | $1,897,000 | -36.1% | 286,967 | -0.5% | 0.68% | -28.2% |
| HRC | Sell | HILL-ROM HOLDINGS INC | $1,732,000 | +4.1% | 34,442 | -0.5% | 0.62% | +16.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.